Sarah Cannon Research Institute at St. David's South Austin is a clinical research site located in Austin, Texas, United States 78704.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute at St. David's South Austin has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed.
Sponsors: Marker Therapeutics, Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute at St. David's South Austin has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute at St. David's South Austin has 1 clinical trials on record, with 1 currently active. Their work covers Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory, Non-Hodgkin Lymphoma, Relapsed.
Sarah Cannon Research Institute at St. David's South Austin has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.